Presentation is loading. Please wait.

Presentation is loading. Please wait.

Risk of congenital malformations for asthmatic pregnant women using a long-acting β2- agonist and inhaled corticosteroid combination versus higher-dose.

Similar presentations


Presentation on theme: "Risk of congenital malformations for asthmatic pregnant women using a long-acting β2- agonist and inhaled corticosteroid combination versus higher-dose."— Presentation transcript:

1 Risk of congenital malformations for asthmatic pregnant women using a long-acting β2- agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy  Sherif Eltonsy, MSc, Amelie Forget, MSc, Marie-France Beauchesne, PharmD, Lucie Blais, PhD  Journal of Allergy and Clinical Immunology  Volume 135, Issue 1, Pages e2 (January 2015) DOI: /j.jaci Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Cohort flow diagram and subcohort selection process. OCS, Oral corticosteroid. Journal of Allergy and Clinical Immunology  , e2DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions


Download ppt "Risk of congenital malformations for asthmatic pregnant women using a long-acting β2- agonist and inhaled corticosteroid combination versus higher-dose."

Similar presentations


Ads by Google